1. Hypoxia-inducible factor (HIF)–mediated effects of the hypoxic niche in bone cancer
   Helen J. Knowles, 2022, Bone Cancer CrossRef
2. Hypoxia‐Inducible Factor‐2α Signaling in the Skeletal System
   Sarah V Mendoza et al, 2023, JBMR Plus CrossRef
3. Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability
   Marina Pierrevelcin et al, 2020, Cells CrossRef
4. miR-142-5p regulates pancreatic cancer cell proliferation and apoptosis by regulation of RAP1A
   Rong Yao et al, 2019, Pathology - Research and Practice CrossRef
5. Targeting HIF-2α as therapy for advanced cancers
   Thanabal Murugesan et al, 2018, Drug Discovery Today CrossRef
6. Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications
   Wei Sun et al, 2019, Cells CrossRef
7. A Comprehensive Description of Hypoxia-inducible Factor 2α Inhibitors as Anticancer Agents: A Mini-review
   Hongyuan Lu et al, 2023, Current Medicinal Chemistry CrossRef
8. Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis
   T. Zhang et al, 2018, BMC Cancer CrossRef
9. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9
   Zhi-Fu Li et al, 2022, Chemico-Biological Interactions CrossRef
10. Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
    Yiming Zhang et al, 2022, Frontiers in Oncology CrossRef